图书馆订阅: Guest
神经生物学评论综述™

每年出版 3 

ISSN 打印: 0892-0915

ISSN 在线: 2375-0014

SJR: 0.121

Molecular Aspects of Cannabinoid Receptors

卷 11, 册 2-3, 1997, pp. 143-166
DOI: 10.1615/CritRevNeurobiol.v11.i2-3.30
Get accessGet access

摘要

Two cannabinoid receptors are reviewed with regard to their primary structure, ligand-binding properties, and signal transduction systems. Both receptors have been cloned; therefore, the expression of their genes and the functional domains within the proteins can be examined. Binding of tritiated agonists has localized these receptors to the central nervous and immune systems. The CB1 receptor is predominantly expressed in brain tissues and is found in both glial elements and neurons; subcellular localization to axons and terminals is evident. This receptor is found in motor, limbic, associative, cognitive, sensory, and autonomic brain structures. CB1 receptors modulate the activities of calcium and potassium channels. The CB2 receptor is predominantly expressed in the immune system and is found in spleen, tonsils, thymus, mast cells, and blood cells. Although receptors appear to be involved in cannabimimetic-induced modulation of immune cell function, the receptor subtype that is principally involved in specific effects is difficult to determine because both receptors are often coexpressed in the same cells. Cannabimimetic-induced effects on mast cells and B cells appear, however, to be mediated by CB2 receptors.

对本文的引用
  1. Sundram Suresh, Castle David, Cannabis and the brain, in Translation of Addictions Science Into Practice, 2007. Crossref

  2. Xiang Jia-Ning, Lee John C., , 34, 1999. Crossref

  3. Upreti Chirag, Zhang Xiao-lei, Alford Simon, Stanton Patric K., Role of presynaptic metabotropic glutamate receptors in the induction of long-term synaptic plasticity of vesicular release, Neuropharmacology, 66, 2013. Crossref

  4. Han C. J., Robinson John K., Cannabinoid modulation of time estimation in the rat., Behavioral Neuroscience, 115, 1, 2001. Crossref

  5. Calignano Antonio, La Rana Giovanna, Loubet-Lescoulié Patrick, Piomelli Daniele, A role for the endogenous cannabinoid system in the peripheal control of pain initiation, in Nervous System Plasticity and Chronic Pain, 129, 2000. Crossref

  6. Ständer S., Reinhardt H. W., Luger T. A., Topische Cannabinoidagonisten, Der Hautarzt, 57, 9, 2006. Crossref

  7. Ranganathan Mohini, D’Souza Deepak Cyril, The acute effects of cannabinoids on memory in humans: a review, Psychopharmacology, 188, 4, 2006. Crossref

  8. Zheng H., Zhao J., Wang S., Lin C.-M., Chen T., Jones D.H., Ma C., Opella S., Xie X.-Q., Biosynthesis and purification of a hydrophobic peptide from transmembrane domains of G-protein-coupled CB2 receptor, Journal of Peptide Research, 65, 4, 2005. Crossref

  9. Gong Jianping, Leonard Claire, Akinshola Babatunde, Onaivi Emmanuel, Lin Zhicheng, Uhl George, Ishiguro Hiroki, Wu Zhang Ping, Chirwa Sanika, Endocannabinoid Receptor Genetics and Marijuana Use, in Endocannabinoids, 2005. Crossref

  10. Pertwee Roger G., Neuropharmacology and therapeutic potential of cannabinoids, Addiction Biology, 5, 1, 2000. Crossref

  11. Burkman Lani, Schuel Herbert, Endocannabinoids in Fertilization, Pregnancy, and Development, in Endocannabinoids, 2005. Crossref

  12. Frankle Gordon W., Neuroreceptor Imaging Studies in Schizophrenia, Harvard Review of Psychiatry, 15, 5, 2007. Crossref

  13. The Relaxation System, in The Scientific Basis of Integrative Medicine, Second Edition, 2009. Crossref

  14. Onaivi Emmanuel S., Cannabinoid Receptors in Brain, in New Concepts of Psychostimulant Induced Neurotoxicity, 88, 2009. Crossref

  15. Schuel Herbert, Burkman Lani J., Lippes Jack, Crickard Kent, Mahony Mary C., Giuffrida Andrea, Picone Robert P., Makriyannis Alexandros, Evidence that anandamide-signaling regulates human sperm functions required for fertilization, Molecular Reproduction and Development, 63, 3, 2002. Crossref

  16. Yeliseev Alexei A., Wong Karen K., Soubias Olivier, Gawrisch Klaus, Expression of human peripheral cannabinoid receptor for structural studies, Protein Science, 14, 10, 2005. Crossref

  17. Spicuzza Lucia, Haddad El-Bdaoui, Birrell Mark, Ling Andrea, Clarke Deborah, Venkatesan Priya, Barnes Peter J, Belvisi Maria G, Characterization of the effects of cannabinoids on guinea-pig tracheal smooth muscle tone: role in the modulation of acetylcholine release from parasympathetic nerves, British Journal of Pharmacology, 130, 7, 2000. Crossref

  18. Hsieh C., Brown S., Derleth C., Mackie K., Internalization and Recycling of the CB1 Cannabinoid Receptor, Journal of Neurochemistry, 73, 2, 2002. Crossref

  19. Colizzi Marco, Fazio Leonardo, Ferranti Laura, Porcelli Annamaria, Masellis Rita, Marvulli Daniela, Bonvino Aurora, Ursini Gianluca, Blasi Giuseppe, Bertolino Alessandro, Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis Use Interact on Prefrontal Connectivity and Related Working Memory Behavior, Neuropsychopharmacology, 40, 3, 2015. Crossref

  20. Kupczyk Piotr, Reich Adam, Szepietowski Jacek C., Cannabinoid system in the skin - a possible target for future therapies in dermatology, Experimental Dermatology, 18, 8, 2009. Crossref

  21. O’Neill Carmel, Evers-Donnelly Alex, Nicholson David, O’Boyle Kathy M., O’Connor John J., D2receptor-mediated inhibition of dopamine release in the rat striatumin vitrois modulated by CB1receptors: studies using fast cyclic voltammetry, Journal of Neurochemistry, 108, 3, 2009. Crossref

  22. Gardner Brian, Zu Li X., Sharma Sherven, Liu Qian, Makriyannis Alexandros, Tashkin Donald P., Dubinett Steven M., Autocrine and Paracrine Regulation of Lymphocyte CB2 Receptor Expression by TGF-β, Biochemical and Biophysical Research Communications, 290, 1, 2002. Crossref

  23. Pharmacology of Intracellular Ca2+, in Intracellular Calcium, 2014. Crossref

  24. Bibliography, in Intracellular Calcium, 2014. Crossref

  25. Zhang Hai-Ying, Bi Guo-Hua, Li Xia, Li Jie, Qu Hong, Zhang Shi-Jian, Li Chuan-Yun, Onaivi Emmanuel S, Gardner Eliot L, Xi Zheng-Xiong, Liu Qing-Rong, Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self-Administration in Mice and Rats, Neuropsychopharmacology, 40, 4, 2015. Crossref

  26. Oladosu Folabomi A., Maixner William, Nackley Andrea G., Alternative Splicing of G Protein–Coupled Receptors: Relevance to Pain Management, Mayo Clinic Proceedings, 90, 8, 2015. Crossref

  27. Grundmann Sonja A., Ständer Sonja, Cannabinoids and Pruritus, in Skin Moisturization, 2009. Crossref

  28. Benington Joel H, Frank Marcos G, Cellular and molecular connections between sleep and synaptic plasticity, Progress in Neurobiology, 69, 2, 2003. Crossref

  29. Ong W.Y, Mackie K, A light and electron microscopic study of the CB1 cannabinoid receptor in primate brain, Neuroscience, 92, 4, 1999. Crossref

  30. Kunos George, Járai Zoltán, Bátkai Sándor, Goparaju Sravan Kumar, Ishac Edward J.N, Liu Jie, Wang Lei, Wagner Jens A, Endocannabinoids as cardiovascular modulators, Chemistry and Physics of Lipids, 108, 1-2, 2000. Crossref

  31. Matveyeva Marina, Hartmann Constance B, Harrison M.Travis, Cabral Guy A, McCoy Kathleen L, Delta9-tetrahydrocannabinol selectively increases aspartyl cathepsin D proteolytic activity and impairs lysozyme processing by macrophages, International Journal of Immunopharmacology, 22, 5, 2000. Crossref

  32. Elias Alan N., Hofflich Heather, Abnormalities in Glucose Metabolism in Patients with Schizophrenia Treated with Atypical Antipsychotic Medications, The American Journal of Medicine, 121, 2, 2008. Crossref

  33. Onaivi Emmanuel S., Leonard Claire M., Ishiguro Hiroki, Zhang Ping Wu, Lin Zhicheng, Akinshola Babatunde E., Uhl George R., Endocannabinoids and cannabinoid receptor genetics, Progress in Neurobiology, 66, 5, 2002. Crossref

  34. Ameri Angela, The effects of cannabinoids on the brain, Progress in Neurobiology, 58, 4, 1999. Crossref

  35. Kikuno Reiko, Daiyasu Hiromi, Toh Hiroyuki, Molecular Evolution of Proteins Involved in the Arachidonic Acid Cascade, in Comprehensive Natural Products Chemistry, 1999. Crossref

  36. Schuel Herbert, Burkman Lani J., Lippes Jack, Crickard Kent, Forester Ellyn, Piomelli Daniele, Giuffrida Andrea, N-Acylethanolamines in human reproductive fluids, Chemistry and Physics of Lipids, 121, 1-2, 2002. Crossref

  37. Alexander Steve P.H., CB-1 Cannabinoid Receptor, in xPharm: The Comprehensive Pharmacology Reference, 2007. Crossref

  38. Golech Susanne Andrea, McCarron Richard M., Chen Ye, Bembry Joliet, Lenz Frederick, Mechoulam Raphael, Shohami Esther, Spatz Maria, Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors, Molecular Brain Research, 132, 1, 2004. Crossref

  39. Goparaju Sravan Kumar, Ueda Natsuo, Yamaguchi Hiroko, Yamamoto Shozo, Anandamide amidohydrolase reacting with 2-arachidonoylglycerol, another cannabinoid receptor ligand, FEBS Letters, 422, 1, 1998. Crossref

  40. Wade Mark R., Tzavara Eleni T., Nomikos George G., Cannabinoids reduce cAMP levels in the striatum of freely moving rats: an in vivo microdialysis study, Brain Research, 1005, 1-2, 2004. Crossref

  41. Alexander Steve P.H., Cannabinoid Receptors, in xPharm: The Comprehensive Pharmacology Reference, 2007. Crossref

  42. Tarzia Giorgio, Duranti Andrea, Tontini Andrea, Spadoni Gilberto, Mor Marco, Rivara Silvia, Vincenzo Plazzi Pier, Kathuria Satish, Piomelli Daniele, Synthesis and structure–activity relationships of a series of pyrrole cannabinoid receptor agonists, Bioorganic & Medicinal Chemistry, 11, 18, 2003. Crossref

  43. Wenger T., Moldrich G., The role of endocannabinoids in the hypothalamic regulation of visceral function, Prostaglandins, Leukotrienes and Essential Fatty Acids (PLEFA), 66, 2-3, 2002. Crossref

  44. Shabani M., Hosseinmardi N., Haghani M., Shaibani V., Janahmadi M., Maternal exposure to the CB1 cannabinoid agonist WIN 55212–2 produces robust changes in motor function and intrinsic electrophysiological properties of cerebellar Purkinje neurons in rat offspring, Neuroscience, 172, 2011. Crossref

  45. Irving A.J, Coutts A.A, Harvey J, Rae M.G, Mackie K, Bewick G.S, Pertwee R.G, Functional expression of cell surface cannabinoid CB1 receptors on presynaptic inhibitory terminals in cultured rat hippocampal neurons, Neuroscience, 98, 2, 2000. Crossref

  46. Whan Lynne B., West Mhairi C.L., McClure Neil, Lewis Sheena E.M., Effects of delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in marijuana, on human sperm function in vitro, Fertility and Sterility, 85, 3, 2006. Crossref

  47. Lau Alaster H.Y., Chow Sharron S.M., Effects of cannabinoid receptor agonists on immunologically induced histamine release from rat peritoneal mast cells, European Journal of Pharmacology, 464, 2-3, 2003. Crossref

  48. McGlone Francis, Reilly David, The Somatosensory System, in Sensitive Skin Syndrome, 2006. Crossref

  49. Zhang Hui, Sulzer David, Regulation of striatal dopamine release by presynaptic auto- and heteroreceptors, Basal Ganglia, 2, 1, 2012. Crossref

  50. Sinha Debasish, Bonner Tom I, Bhat Narayan R, Matsuda Lisa A, Expression of the CB1 cannabinoid receptor in macrophage-like cells from brain tissue: immunochemical characterization by fusion protein antibodies, Journal of Neuroimmunology, 82, 1, 1998. Crossref

  51. Baron Eric P., Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been …, Headache: The Journal of Head and Face Pain, 55, 6, 2015. Crossref

  52. Fu Hui, Xiao Jian Min, Cao Xue Hong, Ming Zhang Yin, Liu Lie Ju, Effects of WIN55,212-2 on voltage-gated sodium channels in trigeminal ganglion neurons of rats, Neurological Research, 30, 1, 2008. Crossref

  53. Kalifa Sara, Polston Eva K., Allard Joanne S., Manaye Kebreten F., Distribution patterns of cannabinoid CB1 receptors in the hippocampus of APPswe/PS1ΔE9 double transgenic mice, Brain Research, 1376, 2011. Crossref

  54. Alexander Steve P.H., CB-2 Cannabinoid Receptor, in xPharm: The Comprehensive Pharmacology Reference, 2007. Crossref

  55. Cannon Christopher P., The endocannabinoid system:A new approach to control cardiovascular disease, Clinical Cornerstone, 7, 2-3, 2005. Crossref

  56. Ziment Irwin, Tashkin Donald P., Alternative medicine for allergy and asthma, Journal of Allergy and Clinical Immunology, 106, 4, 2000. Crossref

  57. Onaivi Emmanuel S., Chaudhuri Gautam, Abaci Asli S., Parker Monica, Manier Donald H., Martin Peter R., Hubbard John R., Expression of cannabinoid receptors and their gene transcripts in human blood cells, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 23, 6, 1999. Crossref

  58. Berdyshev E.V, Cannabinoid receptors and the regulation of immune response, Chemistry and Physics of Lipids, 108, 1-2, 2000. Crossref

  59. Akopian Armen N., Ruparel Nikita B., Jeske Nathaniel A., Patwardhan Amol, Hargreaves Kenneth M., Role of ionotropic cannabinoid receptors in peripheral antinociception and antihyperalgesia, Trends in Pharmacological Sciences, 30, 2, 2009. Crossref

  60. Ständer Sonja, Schmelz Martin, Metze Dieter, Luger Thomas, Rukwied Roman, Distribution of cannabinoid receptor 1 (CB1) and 2 (CB2) on sensory nerve fibers and adnexal structures in human skin, Journal of Dermatological Science, 38, 3, 2005. Crossref

  61. Oz Murat, Receptor-independent actions of cannabinoids on cell membranes: Focus on endocannabinoids, Pharmacology & Therapeutics, 111, 1, 2006. Crossref

  62. Shire David, Calandra Bernard, Bouaboula Monsif, Barth Francis, Rinaldi-Carmona Murielle, Casellas Pierre, Ferrara Pascual, Cannabinoid receptor interactions with the antagonists SR 141716A and SR 144528, Life Sciences, 65, 6-7, 1999. Crossref

  63. Darmani Nissar A, Delta-9-tetrahydrocannabinol differentially suppresses cisplatin-induced emesis and indices of motor function via cannabinoid CB1 receptors in the least shrew, Pharmacology Biochemistry and Behavior, 69, 1-2, 2001. Crossref

  64. Kunos George, Járai Zoltán, Varga Károly, Liu Jie, Wang Lei, Wagner Jens A, Cardiovascular effects of endocannabinoids—the plot thickens, Prostaglandins & Other Lipid Mediators, 61, 1-2, 2000. Crossref

  65. Taurisano Paolo, Antonucci Linda A., Fazio Leonardo, Rampino Antonio, Romano Raffaella, Porcelli Annamaria, Masellis Rita, Colizzi Marco, Quarto Tiziana, Torretta Silvia, Di Giorgio Annabella, Pergola Giulio, Bertolino Alessandro, Blasi Giuseppe, Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use, Cortex, 81, 2016. Crossref

  66. Lehrmann E, Chen J, Lee C, Freed W, Becker K, Microarray Analysis of Lipid Metabolism in Drug Abuse, Neurological and Psychiatric Disorders, in Unraveling Lipid Metabolism With Microarrays, 2004. Crossref

  67. Ambrosini Annarina, Fiorini Rosamaria, Zolese Giovanna, Endocannabinoids and Human Sperm Cells, Pharmaceuticals, 3, 10, 2010. Crossref

  68. Graham E.S., Angel C.E., Schwarcz L.E., Dunbar P.R., Glass M., Detailed Characterisation of CB2 Receptor Protein Expression in Peripheral Blood Immune Cells from Healthy Human Volunteers Using Flow Cytometry, International Journal of Immunopathology and Pharmacology, 23, 1, 2010. Crossref

  69. Basavarajappa Balapal S., Cannabinoid Receptors and Their Signaling Mechanisms, in The Endocannabinoid System, 2017. Crossref

  70. De Petrocellis Luciano, Nabissi Massimo, Santoni Giorgio, Ligresti Alessia, Actions and Regulation of Ionotropic Cannabinoid Receptors, in Cannabinoid Pharmacology, 80, 2017. Crossref

  71. RODRÍGUEZ de FONSECA FERNANDO, DEL ARCO IGNACIO, BERMUDEZ-SILVA FRANCISCO JAVIER, BILBAO AINHOA, CIPPITELLI ANDREA, NAVARRO MIGUEL, THE ENDOCANNABINOID SYSTEM: PHYSIOLOGY AND PHARMACOLOGY, Alcohol and Alcoholism, 40, 1, 2005. Crossref

  72. Lu D., Potter D.E., Cannabinoids and the Cannabinoid Receptors: An Overview, in Handbook of Cannabis and Related Pathologies, 2017. Crossref

  73. Wisneski Len, The Relaxation System Theoretical Construct, in The Scientific Basis of Integrative Health, 2017. Crossref

  74. Giuffrida A., Parsons L. H., Kerr T. M., de Fonseca F. Rodríguez, Navarro M., Piomelli D., Dopamine activation of endogenous cannabinoid signaling in dorsal striatum , Nature Neuroscience, 2, 4, 1999. Crossref

  75. Menahem S., Cardiovascular Effects of Cannabis Usage, in Handbook of Cannabis and Related Pathologies, 2017. Crossref

  76. Bear Mark F., Connors Barry W., Paradiso Michael A., Neurotransmittersysteme, in Neurowissenschaften, 2018. Crossref

  77. Marzo Vincenzo Di, The Endocannabinoid System, Journal of Cannabis Therapeutics, 1, 1, 2001. Crossref

  78. Piomelli Daniele, Pot of gold for glioma therapy, Nature Medicine, 6, 3, 2000. Crossref

  79. Schuel Herbert, Chang Michael C., Burkman Lani J., Picone Robert P., Makriyannis Alexandros, Zimmerman Arthur M., Zimmerman Selma, Cannabinoid Receptors in Sperm, in Marihuana and Medicine, 1999. Crossref

  80. Sundram Suresh, Dean Brian, Copolov David, The endogenous cannabinoid system in schizophrenia, in Marijuana and Madness, 2004. Crossref

  81. Xi Zheng‐Xiong, Muldoon Pretal, Wang Xiao‐Fei, Bi Guo‐Hua, Damaj M. Imad, Lichtman Aron H., Pertwee Roger G., Gardner Eliot L., Δ 8 ‐Tetrahydrocannabivarin has potent anti‐nicotine effects in several rodent models of nicotine dependence , British Journal of Pharmacology, 176, 24, 2019. Crossref

  82. Zhu Li X., Sharma Sherven, Stolina Marina, Gardner Brian, Roth Michael D., Tashkin Donald P., Dubinett Steven M., Δ-9-Tetrahydrocannabinol Inhibits Antitumor Immunity by a CB2 Receptor-Mediated, Cytokine-Dependent Pathway, The Journal of Immunology, 165, 1, 2000. Crossref

  83. Basavarajappa B. S., Yalamanchili R., Cooper T. B., Hungund B. L., The Endocannabinoid System, in Handbook of Neurochemistry and Molecular Neurobiology, 2008. Crossref

  84. Vemuri V. Kiran, Makriyannis Alexandros, Endocannabinoids and Their Synthetic Analogs, in The Cannabinoid Receptors, 2009. Crossref

  85. Sutin Kenneth M., Nahas Gabriel G., Physiological and Pharmacological Interactions of Marihuana (THC) with Drugs and Anesthetics, in Marihuana and Medicine, 1999. Crossref

  86. Mackie K., Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System, in Cannabinoids, 168, 2005. Crossref

  87. Khuja Iman, Yekhtin Zhanna, Or Reuven, Almogi-Hazan Osnat, Cannabinoids Reduce Inflammation but Inhibit Lymphocyte Recovery in Murine Models of Bone Marrow Transplantation, International Journal of Molecular Sciences, 20, 3, 2019. Crossref

  88. KYROU I., VALSAMAKIS G., TSIGOS C., The Endocannabinoid System as a Target for the Treatment of Visceral Obesity and Metabolic Syndrome, Annals of the New York Academy of Sciences, 1083, 1, 2006. Crossref

  89. Kaplan Barbara L. Faubert, Rockwell Cheryl E., Kaminski Norbert E., Evidence for Cannabinoid Receptor-Dependent and -Independent Mechanisms of Action in Leukocytes, Journal of Pharmacology and Experimental Therapeutics, 306, 3, 2003. Crossref

  90. Gregus Ann M., Buczynski Matthew W., Druggable Targets in Endocannabinoid Signaling, in Druggable Lipid Signaling Pathways, 1274, 2020. Crossref

  91. Kopach Olga, Vats Juliana, Netsyk Olga, Voitenko Nana, Irving Andrew, Fedirko Nataliya, Cannabinoid receptors in submandibular acinar cells: functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling, Journal of Cell Science, 2012. Crossref

  92. Colleran Kathleen, Pai Hemanth, Rimonabant: a novel approach for the treatment of obesity and cardiometabolic risk by blockade of the endocannabinoid system, Future Cardiology, 3, 5, 2007. Crossref

  93. Alfulaij Naghum, Meiners Franziska, Michalek Justin, Small‐Howard Andrea L., Turner Helen C., Stokes Alexander J., Cannabinoids, the Heart of the Matter, Journal of the American Heart Association, 7, 14, 2018. Crossref

  94. Suresh Sundram Brian Dean, Copolov David, Postmortem studies of the brain cannabinoid system in schizophrenia, in Marijuana and Madness, 2011. Crossref

  95. Shirazi Rahau S., Vyssotski Mikhail, Lagutin Kirill, Thompson Dion, MacDonald Christa, Luscombe Vincent, Glass Michelle, Parker Kim, Gowing Emma K., Williams D. Bradley G., Clarkson Andrew N., Neuroprotective activity of new Δ3‐N ‐acylethanolamines in a focal ischemia stroke model , Lipids, 57, 1, 2022. Crossref

  96. Dasram Mendhi Henna, Walker Roderick B., Khamanga Sandile M., Recent Advances in Endocannabinoid System Targeting for Improved Specificity: Strategic Approaches to Targeted Drug Delivery, International Journal of Molecular Sciences, 23, 21, 2022. Crossref

Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集 订购及政策 Begell House 联系我们 Language English 中文 Русский Português German French Spain